Hemostemix, Inc. (HEM.V)
0.055
0.00 (0.00%)
CAD |
TSXV |
Oct 23, 16:00
Hemostemix Net Income (Quarterly) : -0.6324M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6324M |
| March 31, 2026 | -0.79M |
| December 31, 2025 | -2.622M |
| September 30, 2025 | -0.4728M |
| June 30, 2025 | -0.2288M |
| March 31, 2025 | -1.285M |
| December 31, 2024 | -1.307M |
| September 30, 2024 | -0.3146M |
| June 30, 2024 | -0.5193M |
| March 31, 2024 | -0.4755M |
| December 31, 2023 | -0.6836M |
| September 30, 2023 | -0.2572M |
| June 30, 2023 | -0.2849M |
| March 31, 2023 | -1.276M |
| December 31, 2022 | -1.347M |
| September 30, 2022 | -0.8105M |
| June 30, 2022 | -1.446M |
| March 31, 2022 | -1.635M |
| December 31, 2021 | -3.216M |
| September 30, 2021 | -1.045M |
| June 30, 2021 | -1.342M |
| March 31, 2021 | -0.6837M |
| December 31, 2020 | -3.989M |
| September 30, 2020 | -1.614M |
| June 30, 2020 | -2.025M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1402M |
| December 31, 2019 | -0.6115M |
| September 30, 2019 | -1.362M |
| June 30, 2019 | -1.326M |
| March 31, 2019 | -1.570M |
| December 31, 2018 | -1.739M |
| September 30, 2018 | -1.703M |
| June 30, 2018 | -1.659M |
| March 31, 2018 | -1.081M |
| December 31, 2017 | -0.4371M |
| September 30, 2017 | -1.869M |
| June 30, 2017 | -0.3821M |
| March 31, 2017 | -0.3587M |
| December 31, 2016 | -0.8582M |
| September 30, 2016 | -1.603M |
| June 30, 2016 | -0.6368M |
| March 31, 2016 | -0.6866M |
| December 31, 2015 | -1.163M |
| September 30, 2015 | -0.9754M |
| June 30, 2015 | -0.9574M |
| March 31, 2015 | -0.8889M |
| May 31, 2014 | -0.0368M |
| February 28, 2014 | -0.0091M |
| November 30, 2013 | -0.0156M |
| August 31, 2013 | -0.0163M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Microbix Biosystems, Inc. | -0.8068M |
| Helix BioPharma Corp. | -0.671M |
| Sernova Biotherapeutics, Inc. | -2.529M |
| Medicenna Therapeutics Corp. | -5.082M |
| Spectral Medical, Inc. | 0.331M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.6324M |
| EPS Diluted (Quarterly) | -0.0031 |
| Enterprise Value | 14.64M |
| Earnings Yield | -44.55% |
| Normalized Earnings Yield | -58.36 |